JPMorgan Lowers XPeng Price Target to $10

October 26, 2026 Analyst: Nick Lai 1 min read Reproduced verbatim
Rating
Hold
Target
$10
from $11.50 (−13%)
Upside
+10%
XPEV at $9.13 today
JP Morgan and XPeng logos

What the analyst said

JPMorgan analyst Nick Lai lowered the price target on XPeng (NYSE: XPEV) to $10.00 (from $11.50) while maintaining a Neutral rating.

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

XPEV trades at $9.13. The 7 analysts who set a target in the last 3 months range from $10 to $22, with a median of $16. This $10 target is 38% below the median, the lowest on the Street.

12-month window: day 0 of 365, closes on October 26, 2027.

Track record

This callOpen: a 12-month target, scored on October 26, 2027, a year after the note.

Firm track recordJP Morgan: 56% of its 16 targets at least a year old were reached within 12 months (#26 of 28 firms). Accuracy ranking →

JP Morgan on XPeng

JP Morgan price targets on XPeng

5 calls from February 9, 2026 to October 26, 2026. The target went from $34 to $10 (−71%). The rating moved from Buy to Hold.

JP Morgan targetXPEV share price
  1. October 26, 2026 This noteTarget cut from $11.50 (−13%)Hold$10
  2. September 29, 2026Downgraded to Hold, target cut from $24 (−52%)Hold$11.50
  3. August 25, 2026Target cut from $30 (−20%)Buy$24
  4. May 29, 2026Target cut from $34 (−12%)Buy$30
  5. February 9, 2026Earliest call shownBuy$34
Share
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.